Status:
UNKNOWN
The Use of International Ovarian Tumor Analysis and Assessment of Adnexal Neoplasia in Differentiating Malignant and Benign Adnexal Masses
Lead Sponsor:
Cairo University
Conditions:
Adnexal Mass
Eligibility:
FEMALE
15-70 years
Brief Summary
All participants will be subjected to Serum measurements of CA-125 by the immunoradiometric assay, Ultrasound evaluation of the Adnexal masses which is described according to origin (ovarian/extraovar...
Detailed Description
All participants will be subjected to Serum measurements of CA-125 by the immunoradiometric assay, Ultrasound evaluation of the Adnexal masses which is described according to origin (ovarian/extraovar...
Eligibility Criteria
Inclusion
- Women with clinically and sonographically diagnosed adenxal mass more than 5 cm in diameter. 2. Patients who will undergo surgical intervention . 3. Patients are recruited regardless of age, parity and complaint
Exclusion
- Patients treated with conservative management. 2. Patients known to be pregnant.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03442881
Start Date
February 1 2018
End Date
December 1 2018
Last Update
February 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Alainy medical school
Cairo, Egypt, 12111